This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease

Measurement of novel lipid and non-lipid biomarkers (ie, apolipoprotein B, apolipoprotein AI, apolipoprotein E, low-density lipoprotein subclass, high-density lipoprotein subclass, lipoprotein [a], B-type natriuretic peptide, cystatin C, fibrinogen, leptin) is considered investigational as an adjunct to low-density lipoprotein cholesterol in the risk assessment and management of cardiovascular disease.

787-277-6653 787-474-6326